Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

NCT05279365 is registered in ClinicalTrials.gov with DHR Health Institute for Research and Development as lead sponsor.

NCT NCT05279365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS
Lead sponsor
DHR Health Institute for Research and Development
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 30, 2021
Completion date
August 31, 2023
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars cov 2 infection